Heightened Focus on Patient Safety to Spur Demand for Patient Prepping Products, Finds Frost & Sullivan

Manufacturers need to focus on providing high quality, end-to-end solutions

Jan 16, 2013, 04:00 ET from Frost & Sullivan

LONDON, Jan. 16, 2013 /PRNewswire/ -- Patient prepping products (PPP) are essential to ensure patient safety. Advantages include cost and time savings and improved efficiency in the allocation of healthcare funds.

New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Western European Patient Prepping Products Market, finds that the market earned revenues of $866.9 million in 2011 and estimates this to reach $1,302.3 million by 2018. The research covers 2 major segments: IV (custom procedure trays and antiseptic prep pads) and surgical (hair removal, antiseptics, incise drapes, and others including oral and nasal prep products).

"An ageing population has had a positive impact on procedure volumes, boosting the uptake of PPP," notes Frost & Sullivan Industry Analyst Beulah Devadason. "Rising awareness about the need to prevent healthcare associated infections (HAI) is also promoting the uptake of PPP."

However, current economic conditions have resulted in hospitals facing increasingly severe budgeting pressures. This, in turn, has affected manufacturers who have resorted to underselling the competition to win tenders.

Nevertheless, such pricing pressures are expected to have a limited impact on market growth. Instead of price, the focus will be on product efficacy since effective products can help avoid the long term costs associated with infection related hospitalization.

This focus on product efficacy, reliability and quality is highlighting the need for a complete solutions provider.

"Market participants recognize the competitive advantage of providing end-to-end solutions," remarks Devadason. "Most Tier I participants have a comprehensive product line or have entered into strategic alliances to expand their existing product portfolio."

The introduction of ChlorhexidineGluconate (CHG) wipes, and iodine diffusing incise drapes represent efforts at product differentiation. They have the potential to shift market dynamics in a slow growth market and are a strategic response from manufacturers to gain market share.

If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

Western European Patient Prepping Products Market is part of the Advanced Medical Technologies Growth Partnership Service programme, which also includes research in the following markets: Custom Procedure Trays and Packs Move Towards Standardisation, Skin Integrity Products Market in Western Europe and Hand Hygiene Champions the Cause of Infection Control. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion
Join Us:           Join our community
Subscribe:       Newsletter on "the next big thing"
Register:         Gain access to visionary innovation

Anna Zanchi
Corporate Communications – Europe
P: 0039 02 46514819
E: anna.zanchi@frost.com

SOURCE Frost & Sullivan